诺和诺德扩大法律行动！对未经批准的司美格鲁肽药物提起14项新诉讼

Core Viewpoint - Novo Nordisk has initiated 14 new lawsuits to protect patients from unsafe, unapproved compounded drugs claiming to contain "semaglutide," emphasizing the need for patients to receive safe and effective treatments from trusted sources [5][9]. Group 1: Legal Actions and Patient Safety - Novo Nordisk has filed a total of 132 lawsuits across 40 states against companies that threaten patient safety through misleading marketing and sales practices [5]. - The new lawsuits focus on pharmacies falsely claiming personalized services to produce unapproved compounded "semaglutide" and remote medical companies improperly guiding patients to use these products [5][9]. - Courts have issued 44 permanent injunctions against defendants illegally compounding "semaglutide" or falsely claiming FDA approval, with some judgments requiring defendants to forfeit profits gained through illegal activities [6]. Group 2: Risks of Compounded Semaglutide - The FDA has issued multiple safety warnings regarding the risks associated with compounded drugs, including cases of patients being hospitalized due to overdosing [7]. - A report from the Brookings Institution highlighted that many compounded "semaglutide" products use synthetic APIs from Chinese factories, some of which lack FDA oversight or quality control [7]. - Notably, 60% of Chinese manufacturers exporting "semaglutide" to the U.S. are banned from doing so in their home country, raising significant safety concerns [7]. Group 3: Public Awareness and Education - Novo Nordisk has launched public awareness campaigns such as "Check Before You Inject" and "Choose The Real Thing" to educate patients about the risks of compounded and counterfeit products [9]. - The company has established a website, semaglutide.com, to inform patients about the risks associated with compounded drugs and how to obtain FDA-approved treatments [9]. - As all dosage forms of Wegovy® and Ozempic® are now available nationwide, the company is exploring new channels for patients to receive safe and effective treatments under licensed medical professionals' supervision [9].